Allogeneic and Autologous Hematopoietic Transplants Can be Safely Performed after COVID-19 Infections

We are in the midst of a pandemic with the COVID-19 virus, a pathogen with potential severe manifestations. A major clinical question is whether it is safe to undergo hematopoietic stem cell transplantation (HSCT) shortly after COVID-19 infection. A total of 21 patients received HSCT following a dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramdial, Jeremy L., Saliba, Rima M., Alousi, Amin M., Rondon, Gabriela, Chen, Julianne, Ledesma, Celina, Shpall, Elizabeth J., Chemaly, Roy, Champlin, Richard E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
721.Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701637/
http://dx.doi.org/10.1182/blood-2021-153997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701637/
http://dx.doi.org/10.1182/blood-2021-153997

Ejemplares similares